[1]陆晓琼,陈秀琼,黄 澄,等.氢吗啡酮硬膜外自控镇痛泵治疗难治性癌痛的疗效观察[J].医学信息,2022,35(05):153-155.[doi:10.3969/j.issn.1006-1959.2022.05.040]
　LU Xiao-qiong,CHEN Xiu-qiong,HUANG Cheng,et al.Effect of Hydromorphone by Self-controlled Epidural Analgesia Pump in Treament of Refractory Cancer Pain[J].Medical Information,2022,35(05):153-155.[doi:10.3969/j.issn.1006-1959.2022.05.040]
点击复制

氢吗啡酮硬膜外自控镇痛泵治疗难治性癌痛的疗效观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年05期
页码:
153-155
栏目:
药物与临床
出版日期:
2022-03-01

文章信息/Info

Title:
Effect of Hydromorphone by Self-controlled Epidural Analgesia Pump in Treament of Refractory Cancer Pain
文章编号:
1006-1959（2022）05-0153-03
作者:
陆晓琼; 陈秀琼; 黄 澄; 等
（广西壮族自治区江滨医院疼痛康复科，广西 南宁 530000）
Author(s):
LU Xiao-qiong; CHEN Xiu-qiong; HUANG Cheng; et al.
(Department of Pain Rehabilitation,Jiangbin Hospital of Guangxi Zhuang Autonomous Region,Nanning 530000,Guangxi,China)
关键词:
难治性癌痛; 氢吗啡酮; 硬膜外自控镇痛泵
Keywords:
Refractory cancer pain; Hydromorphone; Patient-controlled epidural analgesia pump
分类号:
R614
DOI:
10.3969/j.issn.1006-1959.2022.05.040
文献标志码:
A
摘要:
目的 探讨氢吗啡酮硬膜外自控镇痛泵治疗难治性癌痛患者的有效性和安全性。方法 选取2018年3月-2020年12月在广西壮族自治区江滨医院住院治疗的30例难治性癌痛患者，使用硬膜外自控镇痛泵入氢吗啡酮治疗，比较患者治疗前1天及治疗后第1、3、7、30天疼痛评分、药物不良反应以及生活质量。结果 治疗后第1、3、7、30天，患者疼痛评分均较治疗前1天降低，差异有统计学意义（P＜0.05）；治疗后第1、3天，患者恶心呕吐、便秘及头晕的发生率降低，但差异无统计学意义（P＞0.05），治疗后第7、30天，患者恶心呕吐、便秘及头晕的发生率低于治疗前1天，差异有统计学意义（P＜0.05）；治疗7 d后，患者生活质量评分高于治疗前，差异有统计学意义（P＜0.05）。结论 对于难治性癌痛患者，硬膜外自控镇痛泵入氢吗啡酮能减轻疼痛、改善患者生活质量，是一种有效、安全、简便易行的方法。
Abstract:
Objective To observe the clinical efficacy and safety of hydromorphone by self-controlled epidural analgesia pump in treament of refractory cancer pain.Methods A total of 30 30 patients with refractory cancer pain who were hospitalized in Jiangbin Hospital of Guangxi from March 2018 to December 2020 were selected and treated with hydromorphone by self-controlled epidural analgesia pump. The pain score, adverse drug reactions and quality of life of the patients were compared one day before treatment and 1,3,7 and 30 days after treatment.Results On the 1st, 3rd, 7th and 30th day after treatment, the pain scores were lower than those on the 1st day before treatment, and the difference was statistically significant (P<0.05). On the 1st and 3rd day after treatment, the incidence of nausea, vomiting, constipation and dizziness decreased, but the difference was not statistically significant (P>0.05). On the 7th and 30th day after treatment, the incidence of nausea, vomiting, constipation and dizziness was lower than that on the 1st day before treatment, and the difference was statistically significant (P<0.05). After 7 days of treatment, the quality of life score was higher than that before treatment, and the difference was statistically significant (P<0.05).Conclusion Hydromorphone by self-controlled epidural analgesia pump can significantly reduce the cancer pain in patients with refractory cancer pain, improve patients’ quality of life. It is an effective, safe and simple method.

参考文献/References:

[1]Bouhassira D,Luporsi E,Krakowski I.Prevalence and incidence of chronic pain with or without neuropathic characteristics in patients with cancer[J].Pain,2017,158(6):1118-1125.[2]Haumann J,Joosten EBA,Everdingen MHJVDB.Pain prevalence in cancer patients: status quo or opportunities for improvement?[J].Curr Opin Support Palliat Care,2017,11(2):99-104.[3]Afsharimani B,Kindl K,Good P,et al.Pharmacological options for the management of refractory cancer pain-what is the evidence?[J].Support Care Cancer,2015,23(5):1473-1481.[4]Vayne-Bossert P,Afsharimani B,Good P,et al.Interventional options for the management of refractory cancer pain--what is the evidence?[J].Support Care Cancer,2016,24(3):1429-1438.[5]中国抗癌协会癌症康复与姑息治疗专业委员会(CRPC)难治性癌痛学组.难治性癌痛专家共识(2017年版)[J].中国肿瘤临床,2017,44(16):787-793.[6]Pen SD,Pen AD,Hillyer J.Intrathecal Hydromorphone for Intractable Nonmalignant Pain: A Retrospective Study[J].Pain Medicine,2010,7(1):10-15.[7]Caraceni A,Hanks G,Kaasa S,et al.Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC[J].Lancet Oncol,2012,13(2):e58-e68.[8]Swarm RA,Paice JA,Anghelescu DL,et al.Adult Cancer Pain, Version 3.2019,NCCN Clinical Practice Guidelines in Oncology[J].J Natl Compr Canc Netw,2019,17(8):977-1007.[9]The Polyanalgesic Consensus Conference (PACC).Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines[J].Neuromodulation,2017,20(4):405-406.[10]Filippiadis D,Tutton S,Kelekis A.Pain management:The rising role of interventional oncology[J].Diagn Interv Imaging,2017,98(9):627-634.[11]Xing F,Yong RJ,Kaye AD,et al.Intrathecal Drug Delivery and Spinal Cord Stimulation for the Treatment of Cancer Pain[J].Curr Pain Headache Rep,2018,22(2):11.[12]Candido KD,Kusper TM,Knezevic NN.New Cancer Pain Treatment Options[J].Curr Pain Headache Rep,2017,21(2):12.[13]Burton AW,Rajagopal A,Shah HN,et al.Epidural and intrathecal analgesia is effective in treating refractory cancer pain[J]. Pain Med,2004,5(3):239-247.[14]汤洋.吗啡耐受和痛敏的μ受体机制:伤害性感受器μ受体的阻断可预防耐受而不影响吗啡镇痛[J].中国疼痛医学杂志,2018,24(8):576-579.[15]Felden L,Walter C,Harder S,et al.Comparative clinical effects of hydromorphone and morphine:a meta-analysis[J].Br J Anaesth,2011,107(3):319-328.[16]Hong RA,Gibbons KM,Li GY,et al.A retrospective comparison of intrathecal morphine and epidural hydromorphone for analgesia following posterior spinal fusion in adolescents with idiopathic scoliosis[J].Paediatr Anaesth,2017,27(1):91-97.[17]He QH,Liu QL,Li Z,et al.Impact of epidural analgesia on quality of life and pain in advanced cancer patients[J].Pain Manag Nurs,2015,16(3):307-313.[18]Jeleazcov C,Ihmsen H,Saari TI,et al.Patient-controlled Analgesia with Target-controlled Infusion of Hydromorphone in Postoperative Pain Therapy[J].Anesthesiology,2016,124(1):56-68.[19]Ma K,Jin Y,Wang L,et al.Intrathecal delivery of hydromorphone vs morphine for refractory cancer pain:a multicenter,randomized,single-blind,controlled noninferiority trial[J].Pain,2020,161(11):2502-2510.

相似文献/References:

[1]黄艳东.不同剂量氢吗啡酮用于膝关节置换术后硬膜外镇痛的临床观察[J].医学信息,2018,31(01):85.[doi:10.3969/j.issn.1006-1959.2018.01.030]
　HUANG Yan-dong.Clinical Observation of Epidural Analgesia after Knee Arthroplasty with Different Doses of Hydromorphine[J].Medical Information,2018,31(05):85.[doi:10.3969/j.issn.1006-1959.2018.01.030]

更新日期/Last Update: 1900-01-01